COMMUNIQUÉ DE PRESSE publié le 30/10/2023 à 13:30, il y a 2 années 6 mois Magdalena Biosciences, a Joint Venture between Jaguar Health and Filament Health, Receives Second Tranche of Funding from One Small Planet
COMMUNIQUÉ DE PRESSE publié le 26/10/2023 à 14:30, il y a 2 années 6 mois Jaguar Health to Present November 1st at Emerging Growth Conference
COMMUNIQUÉ DE PRESSE publié le 23/10/2023 à 14:30, il y a 2 années 6 mois Magdalena Biosciences Initiates Preclinical Study to Evaluate Plant Extracts to Treat Depression, Anxiety, ADHD and Other Mental Health Indications
COMMUNIQUÉ DE PRESSE publié le 19/10/2023 à 14:30, il y a 2 années 7 mois Independent Study Conducted at Boston Children's Hospital, Harvard Medical School, Shows Potential Utility of Jaguar Health's Crofelemer for Treatment of MVID, a Rare Childhood Disease
COMMUNIQUÉ DE PRESSE publié le 18/10/2023 à 14:30, il y a 2 années 7 mois Napo Pharmaceuticals to Exhibit at the October 25-28 Annual Association of Nurses in AIDS Care (ANAC) Conference for Mytesi, the Company’s FDA-Approved Prescription Drug
COMMUNIQUÉ DE PRESSE publié le 12/10/2023 à 14:30, il y a 2 années 7 mois Jaguar Health to Present October 17 at the Lytham Partners Fall 2023 Investor Conference and October 18 at the BIO Investor Forum
COMMUNIQUÉ DE PRESSE publié le 10/10/2023 à 14:30, il y a 2 années 7 mois Jaguar Animal Health Exhibiting at October 12-14 VCS Annual Conference for Canalevia-CA1, the Company's FDA Conditionally Approved Drug for Chemotherapy-Induced Diarrhea (CID) in Dogs
COMMUNIQUÉ DE PRESSE publié le 28/09/2023 à 14:30, il y a 2 années 7 mois Jaguar Health to Present October 3 at LD Micro's Main Event Investor Conference, and on October 5 at the Global Capital Network Investor Conference
COMMUNIQUÉ DE PRESSE publié le 27/09/2023 à 14:30, il y a 2 années 7 mois Jaguar Health Launches TikTok and Instagram Contest to Raise Awareness About Common Yet Barely Addressed Health Condition: Surprise Diarrhea
COMMUNIQUÉ DE PRESSE publié le 26/09/2023 à 14:30, il y a 2 années 7 mois Napo Pharmaceuticals Supports Groundbreaking Study on Quality of Life for Cancer Patients and Survivors
Publié le 22/05/2026 à 18:05, il y a 1 heure 1 minute Déclaration hebdomadaire d'opérations effectuées du 18 au 22 mai 2026
Publié le 22/05/2026 à 18:05, il y a 1 heure 1 minute Disclosure of transactions in own shares from May 18 to May 22, 2026
Publié le 22/05/2026 à 12:52, il y a 6 heures 14 minutes Communiqué du Conseil d’administration – Assemblée Générale du 22 mai 2026
Publié le 22/05/2026 à 12:52, il y a 6 heures 14 minutes Release from the Board of Directors - Shareholders’ Meeting of May 22, 2026
Publié le 22/05/2026 à 08:30, il y a 10 heures 37 minutes Eiffage is building four solar power plants for the NOOR Atlas programme in Morocco
Publié le 22/05/2026 à 14:04, il y a 5 heures 3 minutes Wi2Wi Corporation Announces First Quarter 2026 Financial Results (Unaudited)
Publié le 22/05/2026 à 14:00, il y a 5 heures 7 minutes Imagine Health Achieves Teaching Facility Status Through University of Calgary Faculty Partnership
Publié le 22/05/2026 à 14:00, il y a 5 heures 7 minutes CCL Industries Inc. Announces Renewal of Normal Course Issuer Bid and Approval of Automatic Securities Purchase Plan
Publié le 22/05/2026 à 14:00, il y a 5 heures 7 minutes Dateline Appoints Alvarez & Marsal to Manage Colosseum Development
Publié le 22/05/2026 à 18:33, il y a 34 minutes Update on Coupon payment due on 23 May 2026 and Preparation of the Green Bond Restructuring
Publié le 22/05/2026 à 18:30, il y a 37 minutes Annual General Meeting of Curatis Holding AG approved all proposals of the Board of Directors
Publié le 22/05/2026 à 18:00, il y a 1 heure 7 minutes VAZIVA SA: Report de la publication du rapport financier annuel 2025 au 29 mai 2026
